<sup>18</sup>F-FDG PET/CT诊断胆管细胞癌的应用价值

doi:10.13491/j.issn.1004-714X.2022.04.020

中国辐射卫生

2022, Vol. 31

Issue (4): 488-493 DOI: 10.13491/j.issn.1004-714X.2022.04.020

论著

本期目录 | 过刊浏览 | 高级检索

¹⁸F-FDG PET/CT诊断胆管细胞癌的应用价值

方娟娟¹, 宋德炜¹, 邵元伟¹, 严守美², 周静³, 焦春雨¹, 刘廷洲¹

1. 德州市第二人民医院影像科，山东德州 253000;
2. 山东省第一医科大学附属肿瘤医院PET中心，山东济南 250000;
3. 山东省第一医科大学附属肿瘤医院腹部放疗一病区，山东济南 250000

Application value of ¹⁸F-FDG PET/CT in the diagnosis of cholangiocarcinoma

FANG Juanjuan¹, SONG Dewei¹, SHAO Yuanwei¹, YAN Shoumei², ZHOU Jing³, JIAO Chunyu¹, LIU Tingzhou¹

1. Department of Medical Imaging, Dezhou Second People's Hospital, Dezhou 253000 China;
2. PET Center, Affiliated Cancer Hospital of Shandong First Medical University, Jinan 250000 China;
3. Department 1 of Abdominal Radiotherapy, Affiliated Cancer Hospital of Shandong First Medical University, Jinan 250000 China

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1661 KB) HTML ( )
输出: BibTeX | EndNote (RIS)

摘要目的探讨¹⁸F-FDG PET/CT诊断胆管细胞癌的应用价值。方法收集2017年9月—2020年10月山东省第一医科大学附属肿瘤医院行PET/CT检查的44例胆管细胞癌患者的病例资料，所有患者均行上腹部CT、MRI及全身PET/CT检查。比较3种检查对胆管细胞癌原发灶、复发灶、区域淋巴结的诊断价值。结果 CT、MRI、PET/CT 3种检查对胆管细胞癌原发灶、区域淋巴结转移的诊断敏感性差异无统计学意义（P > 0.05）；3种检查对胆管细胞癌复发灶的诊断敏感性差异有统计学意义（P < 0.05）。结论 PET/CT检查在胆管细胞癌复发灶的诊断方面具有较高的诊断价值，而3种检查方法在胆管细胞癌原发灶、区域淋巴结转移方面的诊断敏感性差异无统计学意义。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	方娟娟
	宋德炜
	邵元伟
	严守美
	周静
	焦春雨
	刘廷洲

关键词 ：胆管细胞癌, ¹⁸F-FDG, PET/CT

收稿日期: 2022-04-20

PACS:

R816

通讯作者: 周静，E-mail：1371234943@qq.com E-mail: 1371234943@qq.com

作者简介: 方娟娟（1984—），女，山东德州人，主治医师，硕士研究生，从事影像医学与核医学诊断。E-mail：281331993@qq.com

引用本文:

方娟娟, 宋德炜, 邵元伟, 严守美, 周静, 焦春雨, 刘廷洲. ¹⁸F-FDG PET/CT诊断胆管细胞癌的应用价值[J]. 中国辐射卫生, 2022, 31(4): 488-493.
FANG Juanjuan, SONG Dewei, SHAO Yuanwei, YAN Shoumei, ZHOU Jing, JIAO Chunyu, LIU Tingzhou. Application value of ¹⁸F-FDG PET/CT in the diagnosis of cholangiocarcinoma. Chinese Journal of Radiological Health, 2022, 31(4): 488-493.

链接本文:

http://www.zgfsws.com/CN/10.13491/j.issn.1004-714X.2022.04.020 或 http://www.zgfsws.com/CN/Y2022/V31/I4/488

[1] Khan AS, Dageforde LA. Cholangiocarcinoma[J]. Surg Clin North Am, 2019, 99(2): 315-335. DOI: 10.1016/j.suc.2018.12.004
[2] Saha SK, Zhu AX, Fuchs CS, et al. Forty-year trends in cholangiocarcinoma incidence in the U. S. : intrahepatic disease on the rise[J]. Oncologist, 2016, 21(5): 594-599. DOI: 10.1634/theoncologist.2015-0446
[3] Dyson JK, Beuers U, Jones DEJ, et al. Primary sclerosing cholangitis[J]. Lancet, 2018, 391(10139): 2547-2559. DOI: 10.1016/S0140-6736(18)30300-3
[4] 高树全, 崔大鹏. MSCT联合肿瘤标志物检测对肝内肿块型胆管细胞癌的诊断价值[J]. 中华实用诊断与治疗杂志,2018,32(2):166-168. DOI: 10.13507/j.issn.1674-3474.2018.02.018
Gao SQ, Cui DP. Diagnostic value of multi-slice CT combined with the detection of tumor markers to intrahepatic mass-forming type cholangiocarcinoma[J]. J Chin Pract Diagn Ther, 2018, 32(2): 166-168. DOI: 10.13507/j.issn.1674-3474.2018.02.018
[5] 吴仪仪, 左长京. ¹⁸F-FDG PET/CT在诊断胆管细胞癌中的应用[J]. 功能与分子医学影像学(电子版),2015,4(4):815-817
Wu YY, Zuo CJ. Application of ¹⁸F-FDG PET / CT in the diagnosis of cholangiocarcinoma[J]. Funct Mol Med Imaging (Electron Ed), 2015, 4(4): 815-817
[6] Kitajima K, Kita M, Suzuki K, et al. Prognostic significance of SUV max (maximum standardized uptake value) measured by [¹⁸F]FDG PET/CT in endometrial cancer[J]. Eur J Nucl Med Mol Imaging, 2012, 39(5): 840-845. DOI: 10.1007/s00259-011-2057-9
[7] 施杰毅, 高强, 周俭, 等. 第8版AJCC肝内胆管癌TNM分期的解读与验证[J]. 外科理论与实践,2018,23(3):221-226. DOI: 10.16139/j.1007-9610.2018.03.009
Shi JY, Gao Q, Zhou J, et al. Interpretation and validation of 8th edition American joint commission on cancer TNM staging system for intrahepatic cholangiocarcinoma[J]. J Surg Concepts Pract, 2018, 23(3): 221-226. DOI: 10.16139/j.1007-9610.2018.03.009
[8] Lee AJ, Chun YS. Intrahepatic cholangiocarcinoma: the AJCC/UICC 8^th edition updates[J]. Chin Clin Oncol, 2018, 7(5): 52. DOI: 10.21037/cco.2018.07.03
[9] 顾方明, 汪珍光, 杨远, 等. ¹⁸氟-氟代脱氧葡萄糖PET-CT检查在肝内胆管癌分期中的临床价值[J]. 中华消化外科杂志,2019,18(5):499-505. DOI: 10.3760/cma.j.issn.1673-9752.2019.05.017
Gu FM, Wang ZG, Yang Y, et al. Clinical value of Fluorine-18-fluorodeoxyglucose PET-CT examination in intrahepatic cholangiocarcinoma staging[J]. Chin J Dig Surg, 2019, 18(5): 499-505. DOI: 10.3760/cma.j.issn.1673-9752.2019.05.017
[10] Park TG, Yu YD, Park BJ, et al. Implication of lymph node metastasis detected on ¹⁸F-FDG PET/CT for surgical planning in patients with peripheral intrahepatic cholangiocarcinoma[J]. Clin Nucl Med, 2014, 39(1): 1-7. DOI: 10.1097/RLU.0b013e3182867b99
[11] 张占文, 吕清湖, 陈斐妮, 等. ¹⁸氟-脱氧葡萄糖正电子发射计算机断层成像联合同机增强CT对结直肠癌肝转移的诊断价值[J]. 中华胃肠外科杂志,2015,18(3):238-242. DOI: 10.3760/cma.j.issn.1671-0274.2015.03.009
Zhang ZW, Lyu QH, Chen FN, et al. Diagnostic value of ¹⁸F-fluorodexyglucose positron emission tomography combined with contrast enhanced computed tomography in colorectal cancer liver metastasis[J]. Chin J Gastrointest Surg, 2015, 18(3): 238-242. DOI: 10.3760/cma.j.issn.1671-0274.2015.03.009
[12] 王玉静. 血清肿瘤标志物联合检测对肝内胆管细胞癌的诊断价值[J]. 实用癌症杂志,2019,34(3):415-416. DOI: 10.3969/j.issn.1001-5930.2019.03.018
Wang YJ. Diagnostic value of serum tumor markers for intrahepatic cholangiocarcinoma[J]. Pract J Cancer, 2019, 34(3): 415-416. DOI: 10.3969/j.issn.1001-5930.2019.03.018
[13] 周子东, 查悦明, 黄文山, 等. ¹⁸F-FDG PET-CT影像组学鉴别中低分化肝细胞癌和肝内胆管细胞癌[J]. 中华肝脏外科手术学电子杂志,2019,8(2):154-158. DOI: 10.3877/cma.j.issn.2095-3232.2019.02.016
Zhou ZD, Zha YM, Huang WS, et al. Differential diagnosis of moderately-or poorly-differentiated hepatocellular carcinoma from intrahepatic cholangiocarcinoma based on ¹⁸F-FDG PET-CT radiomics features[J]. Chin J Hepat Surg (Electron Ed), 2019, 8(2): 154-158. DOI: 10.3877/cma.j.issn.2095-3232.2019.02.016
[14] 宋昱垚, 刘荣. ¹⁸F-FDG PET/CT在肝门部胆管癌诊治中的应用进展[J]. 山东医药,2017,57(16):111-113. DOI: 10.3969/j.issn.1002-266X.2017.16.038
Song YY, Liu R. Application progress of ¹⁸F-FDG PET/CT in diagnosis and treatment of hilar cholangiocarcinoma[J]. Shandong Med J, 2017, 57(16): 111-113. DOI: 10.3969/j.issn.1002-266X.2017.16.038
[15] 潘中允, 屈婉莹, 周诚, 等. PET/CT诊断学[M]. 北京: 人民卫生出版社, 2009: 596-598.
Pan ZY, Qu WY, Zhou C, et al. Diagnostics of PET/CT[M]. Beijing: People’s Medical Publishing House, 2009: 596-598.
[16] Kim JY, Yun MJ, Lee WJ, et al. Usefulness of ¹⁸F-FDG PET in intrahepatic cholangiocarcinoma[J]. Eur J Nucl Med Mol Imaging, 2003, 30(11): 1467-1472. DOI: 10.1007/s00259-003-1297-8
[17] Roh MS, Jeong JS, kim YH, et al. Diagnostic utility of GLUT1 in the differential diagnosis of liver carcinomas[J]. Hepatogastroenterology, 2004, 51(59): 1315-1318
[18] Wang ZG, Yu MM, Han Y, et al. Correlation of Glut-1 and Glut-3 expression with F-18 FDG uptake in pulmonary inflammatory lesions[J]. Medicine, 2016, 95(48): e5462. DOI: 10.1097/MD.0000000000005462
[19] Alkhawaldeh K, Faltten S, Biersack HJ, et al. The value of F-18 FDG PET in patients with primary sclerosing cholangitis and cholangiocarcinoma using visual and semiquantitative analysis[J]. Clin Nucl Med, 2011, 36(10): 879-883. DOI: 10.1097/RLU.0b013e3182291a64
[20] 刘佩, 张菊, 梁蕊, 等. 影像组学在肝内胆管细胞癌的应用[J]. 磁共振成像,2021,12(3):109-111,115. DOI: 10.12015/issn.1674-8034.2021.03.027
Liu P, Zhang J, Liang R, et al. The application of radiomics in intrahepatic cholangiocarcinoma[J]. Chin J Magn Reson Imaging, 2021, 12(3): 109-111,115. DOI: 10.12015/issn.1674-8034.2021.03.027
[21] 于磊, 刘伟, 尹朝晖, 等. 肝内胆管细胞癌淋巴结转移的CT表现[J]. 中国辐射卫生,2016,25(6):755-757. DOI: 10.13491/j.cnki.issn.1004-714X.2016.06.040
Yu L, Liu W, Yin ZH, et al. CT findings of lymph node metastasis in intrahepatic cholangiocarcinoma[J]. Chin J Radiol Health, 2016, 25(6): 755-757. DOI: 10.13491/j.cnki.issn.1004-714X.2016.06.040
[22] Lee SW, Kim HJ, Park JH, et al. Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma[J]. J Gastroenterol, 2010, 45(5): 560-566. DOI: 10.1007/s00535-009-0188-6